No Data
Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)
Express News | Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target
Sunshine Biopharma Analyst Ratings
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 MRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
Sunshine Biopharma Launches a New Generic Prescription Drug
US Manufacturing Index Rises To 43, Highest Since 2020
MARKET-TEST-DUMMY : Funny thing is I have buy points on both sides. Above for when buying pressure is there and below for major dip. NFA, JUST RISKY OPINIONS
Rhiox OP MARKET-TEST-DUMMY :
so have a lot of others 
Rhiox OP MARKET-TEST-DUMMY : I would do that too, but I haven't had the time lately to learn about options yet. hopefully, after the new year, I will have time to learn.
MARKET-TEST-DUMMY : No options chain here
Rhiox OP MARKET-TEST-DUMMY : oh ok, that why there is no info there.
I thought that what you were talking about when you said both sides, my bad
View more comments...